Replies to post #62648 on Regen BioPharma Inc (RGBP)

[soupoftheday]

For mRNA vaccines, COVID-19 might just be the beginning

Now, scientists are thinking about how mRNA could potentially be used to treat and prevent diseases like Zika and the flu — maybe even cancer.

https://www.minnpost.com/health/2021/05/for-mrna-vaccines-covid-19-might-just-be-the-beginning/

[soupoftheday]

I know this was from 11/12/2015, but now we get to see the results?

"We have previously filed patents and to date have been granted allowance on one, covering compositions of matter capable of silencing NR2F6, means of screening drugs that modulate NR2F6, and various biological activities of this gene. Additionally, we have previously been successful at developing a clinical candidate, dCellVax, which is currently in front of the FDA, as a means of treating cancer. The current program seeks to leverage our existing know-how and intellectual property in order to develop a simple drug candidate applicable to numerous cancers," said Harry Lander, Ph.D., MBA, President of Regen BioPharma. "We are highly enthusiastic about working with Dr. Kesari, a well respected researcher and oncologist in cancer immunotherapy to mature this technology out of the laboratory and into the clinic."

https://www.biospace.com/article/releases/regen-biopharma-initiates-nr2f6-t-cell-immunotherapy-preclinical-program-with-b-dr-santosh-kesari-b-director-of-neuro-oncology-at-john-wayne-can/?keywords=job+search

[soupoftheday]

"The immune system has two arms, the innate, and the adaptive, both of which have been demonstrated to contribute to killing of tumors," said Dr. Kesari. "While dCellVax operates at the level of the innate immune system, the NR2F6 program aims at directly stimulating the adaptive immune system at killing cancer. By initiating these experiments, we hope to offer diversity and potentially synergistic therapies for cancer patients."

https://www.biospace.com/article/releases/regen-biopharma-initiates-nr2f6-t-cell-immunotherapy-preclinical-program-with-b-dr-santosh-kesari-b-director-of-neuro-oncology-at-john-wayne-can/?keywords=job+search